Bill Whitaker reports on the pharmaceutical companies, hospitals and the middlemen in between that feed a cycle in which patients trying to get many generic drugs end up losers.
Ares Management Corporation announced the final closing of Ares Senior Direct Lending Fund II (“SDL II” or the “Fund”). With total equity commitments of approximately $8 billion, SDL II was significantly oversubscribed relative to its initial target of $4.5 billion. The Fund is over 2.6x the size of its 2018 predecessor fund of $3 billion..